Budak Miray, Bayraktaroglu Zubeyir, Hanoglu Lutfu
Functional Imaging and Cognitive-Affective Neuroscience Lab (fINCAN), Research Institute for Health Sciences and Technologies (SABITA), Istanbul Medipol University, Istanbul, Turkey.
Department of Physical Therapy and Rehabilitation, Institute of Health Sciences, Istanbul Medipol University, Istanbul, Turkey.
Cogn Neurodyn. 2023 Feb;17(1):39-61. doi: 10.1007/s11571-022-09818-x. Epub 2022 May 30.
The purpose of this study was to investigate the effects of high-frequency repetitive Transcranial Magnetic Stimulation (rTMS) and aerobic exercises (AE) in addition to the pharmacological therapy (PT) in Alzheimer's Disease (AD). Twenty-seven patients with AD aged ≥ 60 years were included in the study and divided into 3 groups (rTMS, AE and control). All groups received PT. rTMS group (n = 10) received 20 Hz rTMS over dorsolateral prefrontal cortex (dlPFC) bilaterally and AE group (n = 9) received the structured moderate-intensity AE for 5 consecutive days/week over 2 weeks. Control group (n = 8) only received PT. Cognition, balance, mobility, quality of life (QoL), and resting state functional brain activity were evaluated one week before and one week after the interventions. (ClinicalTrials.gov ID:NCT05102045). Significant improvements were found in executive functions, behavior, and QoL in the rTMS group, in balance and mobility in the AE group, and in the visual memory and behavior in the control group ( < 0.05). Significant differences were found in the behavior in favor of the rTMS group, and balance in favor of the AE group ( < 0.05). There was a significant increase in activation on middle temporal gyrus, intra calcarine, central opercular cortex, superior parietal lobule, and paracingulate cortex in Default Mode Network (DMN) in the rTMS group ( < 0.05). High-frequency rTMS over bilateral dlPFC may improve executive functions and behavior and lead to increased activation in DMN, structured moderate-intensity AE may improve balance and mobility, and PT may improve memory and behaviour compared to pretreatment in AD.
本研究的目的是调查高频重复经颅磁刺激(rTMS)和有氧运动(AE)联合药物治疗(PT)对阿尔茨海默病(AD)的影响。本研究纳入了27名年龄≥60岁的AD患者,并将其分为3组(rTMS组、AE组和对照组)。所有组均接受PT。rTMS组(n = 10)接受双侧背外侧前额叶皮质(dlPFC)20Hz的rTMS,AE组(n = 9)连续5天/周、共2周接受结构化中等强度的AE。对照组(n = 8)仅接受PT。在干预前1周和干预后1周评估认知、平衡、活动能力、生活质量(QoL)和静息态脑功能活动。(ClinicalTrials.gov标识符:NCT05102045)。rTMS组在执行功能、行为和QoL方面有显著改善,AE组在平衡和活动能力方面有显著改善,对照组在视觉记忆和行为方面有显著改善(P<0.05)。在行为方面发现rTMS组有显著差异,在平衡方面AE组有显著差异(P<0.05)。rTMS组默认模式网络(DMN)中的颞中回、距状沟内、中央 opercular 皮质、顶上小叶和扣带旁皮质的激活显著增加(P<0.05)。与AD预处理相比,双侧dlPFC的高频rTMS可能改善执行功能和行为,并导致DMN激活增加,结构化中等强度的AE可能改善平衡和活动能力,PT可能改善记忆和行为。